ESM-1 levels were measured in all patients recruited in the study, within the first 24 h of ICU admission (critically ill COVID-19 patients and critically ill non-septic patients), or 6 h following sepsis diagnosis (critically ill septic patients). The gene discussed is ESM1; the disease is COVID-19.